LPCN
Lipocine Inc.Company with tickers: LPCN
CIK
1535955
CUSIP
53630X203
Shares Outstanding
8,244,253
13F Activity (30d)
42 filings
40 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $119,397 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $3,968,861 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $2,764,394 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-3,849,464 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-3,671,894 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |